Aegerion Pharmaceuticals (AEGR -10.1%) says it plans a public offering of 3.4M shares of common...


Aegerion Pharmaceuticals (AEGR -10.1%) says it plans a public offering of 3.4M shares of common stock at $14.75/share, as it looks to raise funds for activities related to the regulatory approval and commercialization of its lipid disorder treatment and lead product candidate lomitapide.

Comments (0)
Be the first to comment
DJIA (DIA) S&P 500 (SPY)
ETF Hub
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs